Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - December 2014


Cold Chain Distribution

02 Dec 2014 - 03 Dec 2014 - London, UK



Bookmark and Share


Join the 9th annual Cold Chain Distribution event and be part of a major networking opportunity providing intimate interaction with your peers, where you will hear case studies, presentations and round table discussions on the key issues surrounding the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products.

In addition, Cold Chain Distribution-2014 includes this fantastic networking opportunity: Dinner at Gordon Ramsay's Maze Restaurant sponsored by World Courier on the evening of December 2nd.

Event Highlights:

  • Hear from MHRA GDP Inspector, Cheryl Blake, will be providing attendees with regulatory guidance in her presentation entitled: GDP Compliance - A UK Regulatory Perspective, on Day 1 of the conference
  • Benchmark and reflect on the implementation of the GDP directive with case studies from IATA, AbbVie and the Dutch Health Care Inspectorate
  • Enhance your understanding of the challenges of transport qualification for temperature sensitive pharmaceutical products with a round table discussion led by Tony Wright, Managing Director, Exelsius Cold Chain Management and an opening address from Alan Dorling, Global Head – Pharmaceutical & Life Sciences, IAG Cargo
  • Strengthen your supply chains through management and efficiency insights from Merck Serono and Genzyme

Speaker Faculty-2014 includes:

  • Gianpiero Lorusso, Supply Chain Manager, Merck Serono 
  • Didier Basseras, VP Global Head of Clinical Supplies & Supply Chain, Sanofi Aventis R&D 
  • Thomas Grubb, Manager, Cold Chain Strategy, American Airlines 
  • Mark Riches, Logistics Manager, Public Health England 
  • Tim Wood, Technical Service Manager, GSK 
  • Michelle Goodyear, QA Manager, AbbVie 
  • Tony Wright, Managing Director, Exelsius Cold Chain Management
  • Chris Wallace, Distribution Director, Genzyme 
  • David Spillett, Business Development Manager, Biopharm Services, World Courier 
  • Alan Dorling, Global Head - Pharmaceuticals & Life Sciences, IAG Cargo

Plus, many more at this year's event.

For more information, contact Fateja Begum on +44 (0) 207 827 6184 or fbegum@smi-online.co.uk



Further information
Scientific News
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Safer, Cheaper, Greener and More Efficient System for Organic Synthesis
The new medium not only supports organic synthesis it also produces considerably higher yields of product than pure organic solvents.
Fighting Prostate Cancer
Identifying the most promising compounds which can be used as medications for prostate cancer.
Collaboration to Develop Cancer Therapeutics
Major license agreement with Merck, enabled by Blavatnik Biomedical Accelerator, aims to develop therapy for most common form of acute leukemia.
Faster UVA Molecular Analysis Technology
There are people in the world – chemical engineers, astronomers, national defense scientists investigating an explosion – who need to know just what something is made of, down to the molecular level.
Scientists Synthesize Anti-Cancer Agent
A team led by Rice University synthetic organic chemist K.C. Nicolaou has developed a new process for the synthesis of a series of potent anti-cancer agents originally found in bacteria.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!